BRAINTRANSPORTER

Live / Applied — First extension granted (statement of use) (as of 08 Dec 2025)

What this means for you

Not registered yet, but its 11 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98494527
Mark type
Stylized text
Filed
11 Apr 2024
Published for opposition
06 May 2025
Attorney of record
Jessica S. Sachs

Goods and services

  • Class 001 — Chemicals: (Based on Intent to Use) Chemical substances, chemical materials and chemical preparations, and natural biological preparation elements for use in manufacture of pharmaceuticals; chemical substances and materials for industrial, scientific and laboratory use other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biochemical substances being biochemical preparations for scientific purposes; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; reagents for scientific, laboratory, analysis, research, medical research, testing, inspection, detecting or verification use other than for medical use; reagents other than for medical or veterinary purposes for use in the development of antibodies for scientific and medical research use; reagents for scientific or medical research use for use in scientific apparatus for chemical or biological analysis; stem cells and reconstituted cells for research or scientific purposes; reconstituted cells for the efficiency and tolerance testing of pharmaceutical products for research or scientific purposes; antibodies and antibodies-based chemicals, except for medical or veterinary use being antibodies and antibodies-based chemicals for scientific purposes; biological preparation for use in cell cultures other than for medical or veterinary use
  • Class 005 — Pharmaceuticals: (Based on Intent to Use) Medical and veterinary preparations for the treatment of disorders of the central nervous system; Medical and veterinary articles namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pharmaceutical preparations and substances for the treatment of disorders of the central nervous system; biochemical preparations for medical use for the treatment of the central nervous system; pharmaceutical preparations and medical preparations for the treatment, prevention and diagnosis of Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases and disorders of the central nervous system; antibodies and antibodies-based pharmaceutical preparations for medical purposes for diagnostic testing relating to disorders of the central nervous system; diagnostic preparations and materials for medical or veterinary purposes; medical therapeutic agents for the central nervous system; reagents for medical use; biochemical biomarkers for medical use; diagnostic biomarker reagents for medical purposes; (Based on Section 44(e)) (Based on Intent to Use) live organs and tissues for surgical implantation purpose; (Based on Intent to Use) cells for medical use; stem cells for medical purposes; (Based on Section 44(e)) (Based on Intent to Use) sanitary preparations for medial purposes; (Based on Intent to Use) dietetic substances, namely dietetic foods, adapted for medical purposes
  • Class 042 — Scientific and technological services: (Based on Intent to Use) scientific and technological services and research, namely, scientific research relating to product development and design in the field of central nervous system disorders; medical and pharmacological research services; medical, pharmaceutical and biotechnological laboratory research services; scientific investigations for medical purposes; conducting clinical trials for others; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; biochemical analysis and research; drug discovery services; pharmaceutical products development and evaluation

Owner

Prosecution history

  • 09 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 08 Dec 2025 — SOU EXTENSION 1 GRANTED
  • 08 Dec 2025 — SOU EXTENSION 1 FILED
  • 08 Dec 2025 — SOU TEAS EXTENSION RECEIVED
  • 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 06 May 2025 — PUBLISHED FOR OPPOSITION
  • 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 10 Apr 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
  • 28 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 12 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 12 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 12 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 19 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 19 Feb 2025 — NON-FINAL ACTION E-MAILED

View this trademark record on Marksy